SOPHiA GENETICS Statistics
Total Valuation
SOPHiA GENETICS has a market cap or net worth of $337.90 million. The enterprise value is $306.89 million.
Important Dates
The next confirmed earnings date is Tuesday, November 4, 2025, before market open.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SOPHiA GENETICS has 67.58 million shares outstanding. The number of shares has increased by 2.18% in one year.
| Current Share Class | 67.58M |
| Shares Outstanding | 67.58M |
| Shares Change (YoY) | +2.18% |
| Shares Change (QoQ) | +0.71% |
| Owned by Insiders (%) | 6.46% |
| Owned by Institutions (%) | 29.39% |
| Float | 50.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.79 |
| Forward PS | 4.11 |
| PB Ratio | 4.41 |
| P/TBV Ratio | 7.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.40 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.39, with a Debt / Equity ratio of 0.83.
| Current Ratio | 3.39 |
| Quick Ratio | 3.03 |
| Debt / Equity | 0.83 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -27.07 |
Financial Efficiency
Return on equity (ROE) is -74.09% and return on invested capital (ROIC) is -28.82%.
| Return on Equity (ROE) | -74.09% |
| Return on Assets (ROA) | -23.46% |
| Return on Invested Capital (ROIC) | -28.82% |
| Return on Capital Employed (ROCE) | -47.04% |
| Revenue Per Employee | $164,747 |
| Profits Per Employee | -$173,511 |
| Employee Count | 423 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 3.52 |
Taxes
In the past 12 months, SOPHiA GENETICS has paid $2.01 million in taxes.
| Income Tax | 2.01M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +48.37% in the last 52 weeks. The beta is 1.10, so SOPHiA GENETICS's price volatility has been higher than the market average.
| Beta (5Y) | 1.10 |
| 52-Week Price Change | +48.37% |
| 50-Day Moving Average | 3.89 |
| 200-Day Moving Average | 3.44 |
| Relative Strength Index (RSI) | 64.03 |
| Average Volume (20 Days) | 143,542 |
Short Selling Information
The latest short interest is 21,773, so 0.03% of the outstanding shares have been sold short.
| Short Interest | 21,773 |
| Short Previous Month | 33,207 |
| Short % of Shares Out | 0.03% |
| Short % of Float | 0.04% |
| Short Ratio (days to cover) | 0.21 |
Income Statement
In the last 12 months, SOPHiA GENETICS had revenue of $69.69 million and -$73.40 million in losses. Loss per share was -$1.10.
| Revenue | 69.69M |
| Gross Profit | 47.23M |
| Operating Income | -67.34M |
| Pretax Income | -71.38M |
| Net Income | -73.40M |
| EBITDA | -65.91M |
| EBIT | -67.34M |
| Loss Per Share | -$1.10 |
Full Income StatementBalance Sheet
The company has $94.82 million in cash and $63.81 million in debt, giving a net cash position of $31.01 million or $0.46 per share.
| Cash & Cash Equivalents | 94.82M |
| Total Debt | 63.81M |
| Net Cash | 31.01M |
| Net Cash Per Share | $0.46 |
| Equity (Book Value) | 76.69M |
| Book Value Per Share | 1.13 |
| Working Capital | 82.55M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$36.72 million and capital expenditures -$263,000, giving a free cash flow of -$36.99 million.
| Operating Cash Flow | -36.72M |
| Capital Expenditures | -263,000 |
| Free Cash Flow | -36.99M |
| FCF Per Share | -$0.55 |
Full Cash Flow StatementMargins
Gross margin is 67.78%, with operating and profit margins of -96.62% and -105.32%.
| Gross Margin | 67.78% |
| Operating Margin | -96.62% |
| Pretax Margin | -102.43% |
| Profit Margin | -105.32% |
| EBITDA Margin | -94.57% |
| EBIT Margin | -96.62% |
| FCF Margin | n/a |
Dividends & Yields
SOPHiA GENETICS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.18% |
| Shareholder Yield | -2.18% |
| Earnings Yield | -21.72% |
| FCF Yield | -10.95% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | 20.92% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SOPHiA GENETICS has an Altman Z-Score of -2.71 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.71 |
| Piotroski F-Score | 2 |
